论文部分内容阅读
目的比较胰岛素泵持续皮下输注胰岛素与多次皮下注射胰岛素治疗初发2型糖尿病的效果与安全性。方法选用空腹血糖>11.1mmol/L的50例初诊2型糖尿病患者随机分组;胰岛素泵持续注射胰岛素组(CCSI组)25例,多次皮下注射胰岛素组(MSII组)25例,比较两种方法治疗前后血糖、胰岛素用量、血糖达标时间及低血糖发病率。结果 CCSI组在血糖达标时间、胰岛素用量及低血糖发病率上均优于MSII组(P<0.05)。结论胰岛素泵治疗初发2型糖尿病是一种有效的方法。
Objective To compare the efficacy and safety of insulin pump with subcutaneous insulin infusion and multiple subcutaneous insulin in the treatment of newly diagnosed type 2 diabetes mellitus. Methods Fifty patients with newly diagnosed type 2 diabetes with fasting blood glucose> 11.1 mmol / L were randomly divided into two groups: 25 in CCSI group, 25 in subcutaneous injection of insulin group (MSII group) Before and after treatment, blood glucose, insulin dosage, blood glucose compliance time and incidence of hypoglycemia. Results The CCSI group was better than the MSII group in the time of reaching the target of blood glucose, the amount of insulin and the incidence of hypoglycemia (P <0.05). Conclusion Insulin pump for the treatment of newly diagnosed type 2 diabetes is an effective method.